The AI healthcare sector is now in a pivotal phase of competition, and iFlytek Medical has stepped into the spotlight with the release of its Spark Medical Large Model V3.5. This model has been meticulously trained on a computing power platform developed entirely within China. With a keen focus on two key areas—clinical diagnosis and treatment, as well as resident health management—the model has proven its ability to effectively transition from laboratory settings to real-world clinical environments. This is evidenced by its deployment and utilization of application data from top-tier tertiary hospitals.

Projections indicate that the domestic AI healthcare market is poised for explosive growth, with estimates suggesting it will exceed RMB 100 billion by 2025 and soar past RMB 150 billion by 2026. This represents a compound annual growth rate of an impressive 30%, with 2026 being heralded as a watershed year for commercialization efforts within the industry.

Currently, there is a noticeable shift in industry consensus towards the deep integration and adaptation of high-quality, exclusive medical data with specific business scenarios. The Spark Medical Large Model V3.5 stands out by achieving significant breakthroughs in areas such as medical voice interaction and automated medical record generation. These advancements underscore its leading position in large-scale applications within real hospital operations, setting a new standard for practical AI healthcare solutions.